Rep. Gus Bilirakis

R

Florida – District 12
representative

Leadership

Republican Leader Consumer Protection and Commerce

117th Congress

Chairman Commerce, Manufacturing, and Trade

119th Congress

News & Announcements

May 21, 2025
Press Release

Subcommittee on CMT Holds Hearing on Seizing America’s AI Opportunity

WASHINGTON, D.C. – Today, Congressman Gus Bilirakis (FL-12), Chairman of the Subcommittee on Commerce, Manufacturing, and Trade, led a hearing titled AI Regulation and the Future of US Leadership .  “Our task is to protect our citizens and ensure that we don’t cede U.S. AI leadership. Much of the AI marketplace is comprised of small start-ups looking to get a foothold in this revolutionary space,” said Chairman Bilirakis. “And heavy-handed regulations may ensure that the next great American company never makes it. If we fail in this task, we risk ceding American leadership in AI to China, which is close on our heels.”  Watch the full hearing here .   Below are key excerpts from today’s hearing: Congressman Russ Fulcher (ID-01): “In the face of Chinese progress in emerging technologies, I'm concerned about the US's ability to maintain its leadership position, if in fact we still have one – I’d like to get your opinion on that – in an AI race. Especially if we were to follow the European approach, which I don't see us doing, or allow a patchwork of AI rules to develop across the various states. So with that, if you could just share, are you confident? Are we still in the lead in AI? And can we continue to maintain the edge in AI technology over China on this path?” Mr. Bhargava: “Yes, I believe the US does still have a lead, but many of the Chinese models are 85 to 90% of the way there to where the cutting-edge US models are. So I'd say it's not a major lead, but we certainly do have a lead from a technology perspective of most of the evaluations of AI models done.” Congressman Jay Obernolte (CA-23): “As the Chairman of the House AI Task Force last year, and as someone who saw this group of 24 members of Congress from both sides all come together on this issue, it really hurts my heart that it's being painted as such a divisive, partisan issue because I don't think it is. You know, the assertions have been made that this was a last-minute thing and ‘in the dead of night.’ I think someone used the phrase ‘it was inserted,’ but I want to talk about the motivation here. It's been very alarming, as we have seen in the first 5 months of this year go by, the number of bills introduced on the topic of AI regulation in state legislatures across the country. Over 1,000 now have been introduced and this is what's lending urgency to this issue.” Congresswoman Laurel Lee (FL-15): “Artificial intelligence is not just the technology of the future. It is already transforming the way that we live, work, and govern, and it is reshaping nearly every sector of our economy. The question before us is not whether to act, it is how to act wisely. So as policy makers, we have two responsibilities. One is to protect the public from real risks, but second, to ensure that American innovation continues to lead the world. Those goals are not mutually exclusive. In fact, the right policy framework can achieve both, so I appreciate you all being here today to help us strike that balance.” ###

May 21, 2025
Hearings

Chairman Bilirakis Delivers Opening Statement at Subcommittee on Commerce, Manufacturing, and Trade Hearing on Seizing America's AI Opportunity

WASHINGTON, D.C . – Congressman Gus Bilirakis (FL-12), Chairman of the Subcommittee on Commerce, Manufacturing, and Trade, delivered the following opening statement at today’s hearing titled AI Regulation and the Future of US Leadership. Subcommittee Chairman Bilirakis' opening statement as prepared for delivery: “Thank you to everyone, especially our witnesses, for joining us for today’s hearing on 'AI Regulation and the Future of U.S. Leadership.' “At the outset, I want to recognize Ranking Member Schakowsky, as this is our first Subcommittee hearing since she announced her retirement. She’s been a welcome partner over the last four-and-a-half years. Together, we were able to secure better safety precautions for women with the FAIR Crash Tests Act. During the pandemic, we worked tirelessly to support the travel and tourism industry at a time of unprecedented challenges. This bond culminated in the TICKET Act, which strengthens consumer protections in the ticketing marketplace. Congress and E&C won’t be the same without Ranking Member Schakowsky, but her legacy will be long remembered. “Since the public release of ChatGPT, AI has become a household name. AI products and services are being developed at breakneck speed, delivering new innovations to consumers. These technologies can revolutionize the economy, drive economic growth, and improve our way of life. Like every technology, however, AI can be weaponized when it is in the wrong hands. Thankfully, AI is already regulated by longstanding laws that protect consumers. Because of the great potential of these technologies, Congress must be careful when we impose additional obligations on AI developers and deployers. “Our task is to protect our citizens and ensure that we don’t cede U.S. AI leadership. Much of the AI marketplace is comprised of small start-ups looking to get a foothold in this revolutionary space. And heavy-handed regulations may ensure that the next great American company never makes it. If we fail in this task, we risk ceding American leadership in AI to China, which is close on our heels. “Other economies are also eager to write the global AI rulebook, often to their own detriment and the detriment of American leadership. The E.U. recently enacted its own 'AI Act.' While it is still being implemented, the E.U.’s complex law suffers from many of the innovation-chilling effects we saw with the GDPR. We must also keep a close watch on whether Europe uses the AI Act and other regulations to unfairly target American companies. “We’re here today to determine how Congress can support the growth of an industry that is key for American competitiveness and jobs, without losing the race to write the global AI rulebook. Our witnesses today will help us understand how we achieve that dream. “I want to thank the witnesses for being here and I look forward to your testimony.” ###

May 14, 2025
Press Release

Chairmen Guthrie and Bilirakis Announce Subcommittee Hearing on Seizing America’s AI Opportunity

WASHINGTON, D.C. – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, and Chairman Gus Bilirakis (FL-12), Chairman of the Subcommittee on Commerce, Manufacturing, and Trade, announced a hearing titled AI Regulation and the Future of US Leadership . “Burdensome and conflicting AI legislation stifles innovation and undermines the success of entrepreneurs. Europe is seeing the effects of their heavy-handed regulations, as they continue to fall further behind on cutting-edge technologies,” said Chairmen Guthrie and Bilirakis. “We look forward to considering a pro-innovation agenda that encourages the development and deployment of AI at scale at home and supports U.S. AI leadership abroad.” Subcommittee on Commerce, Manufacturing, and Trade hearing titled AI Regulation and the Future of US Leadership WHAT: Subcommittee on Commerce, Manufacturing, and Trade hearing on ensuring a pro-innovation AI regulatory environment. DATE: Wednesday, May 21, 2025 TIME: 10:15 AM ET LOCATION: 2322 Rayburn House Office Building This notice is at the direction of the Chairmen. The hearing will be open to the public and press and will be live streamed online at energycommerce.house.gov . If you have any questions concerning the hearing, please contact Alex Khlopin with the Committee staff at Alex.Khlopin@mail.house.gov . If you have any press-related questions, please contact Daniel Kelly at Daniel.Kelly@mail.house.gov . ###

Letters

Apr 17, 2025
Press Release

Chairmen Guthrie, Bilirakis, and Palmer Launch Investigation into 23andMe and its Handling of Americans’ Sensitive Medical and Genetic Information

WASHINGTON, D.C.  – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, Congressman Gus Bilirakis (FL-12), Chairman of the Subcommittee on Commerce, Manufacturing, and Trade, and Congressman Gary Palmer (AL-06), Chairman of the Subcommittee on Oversight and Investigations, sent a letter to 23andMe regarding the handling of Americans' sensitive data following the company's decision to file for bankruptcy. KEY EXCERPT: “According to 23andMe’s privacy statement, in a bankruptcy, customers’ ‘Personal Information may be accessed, sold or transferred as part of that transaction and this Privacy Statement will apply to [customer] Personal Information as transferred to the new entity.’ Additionally, a judge recently ruled 23andMe has the right to sell the sensitive medical and genetic information of its 15 million customers, which is considered to be the company’s most valuable asset. With the lack of a federal comprehensive data privacy and security law, we write to express our great concern about the safety of Americans’ most sensitive personal information.” Background: On March 23, 2025, 23andMe initiated Chapter 11 bankruptcy proceedings, which could have ramifications for the highly sensitive information of millions of Americans. While Americans’ personal health information is protected under the Health Insurance Portability and Accountability Act (HIPAA), these protections only apply if the information is collected by a HIPAA covered entity. Generally, direct-to-consumer companies, like 23andMe, are not covered by HIPAA. Customers have reported issues accessing and deleting their data from their 23andMe accounts. The Chairmen have requested answers to the following questions: If 23andMe were to sell the personal information of its customers either as a standalone asset or as part of a broader sale of the company, what post-sale data privacy and security protections would be in place for its customers’ personal information? Please describe how the representations made in 23andMe’s privacy statement will continue to apply—and be enforced—if the personal information of 23andMe’s customers is sold to a third party. Please include in this response information about what, if anything, would hold a third-party buyer to 23andMe’s privacy statement or prevent it from subsequently using, transferring, or otherwise selling, such information in the future. Does 23andMe plan to change its privacy statement at any time prior to selling any customers’ personal information? If so, please explain the change 23andMe plans to implement and when those changes will go into effect. Does 23andMe intend to vet prospective buyers to which it may sell its customers’ personal information? If so, please detail the vetting process and whether it will include the prospective buyer’s history of implementing data security protections and compliance with sectoral, state, or any other data privacy and security laws. If not, please explain why. Please detail the categories of customer information 23andMe has, and of that what 23andMe is considering selling. Has 23andMe notified its customers of the company’s bankruptcy announcement? If so, please attach the customer notification. If not, please explain why. Has 23andMe provided its customers with a guide for how to delete, or request to delete any information currently in 23andMe’s possession? If so, please provide a copy of that guide and specify when it was provided to customers. If not, please explain why, and explain whether 23andMe will contact each of its customers and provide an opportunity to delete their personal information prior to a potential sale of the company or personal information maintained by the company. Please detail the number of requests 23andMe received from its customers to delete their personal information between when 23andMe filed for bankruptcy and the date of the response to this letter. Of those requests, please provide a breakdown of how many requests were made by customers through their 23andMe online accounts and how many were made via customer service calls because customers were unable to successfully delete their information through their online accounts. Of those requests, please detail the number of fulfilled requests. Will 23andMe offer for sale any information in which a customer has requested the deletion of such information? If so, does 23andMe’s privacy policy consider selling information a legitimate purpose for retaining information past a customer's request to delete their information? Will 23andMe deidentify its customers’ personal information prior to selling it or the company? If so, please detail which information will be deidentified. If not, please explain why the company is electing not to deidentify information. CLICK HERE to read the full letter. CLICK HERE to read the story from CNBC. ###

Dec 19, 2024
Press Release

E&C Republicans Request HHS Watchdog Investigate Promotion of Gender Transition Procedures for Children

Washington, D.C. — In a new letter to Department of Health and Human Services (HHS) Inspector General Christi Grimm, House Energy and Commerce Committee Republicans requested an investigation into the strength, quality, and types of evidence-based scientific and pediatric medical literature relied on by the department to promote gender transition procedures for children.  KEY LETTER EXCERPT:  “As the agency responsible for safeguarding the health and well-being of Americans, all of HHS’s medical treatment recommendations, especially medical treatment recommendations for children, should be based on rigorous and well-established research, such as randomized controlled trials, that have definitively illustrated the long-term benefits of gender affirming care treatments.”  BACKGROUND:  Under the Biden administration, HHS has advocated for sex reassignment procedures on minors, including the use of serum puberty blockers, which have historically been used to treat children with precocious puberty (i.e., early onset puberty affecting about one percent of U.S. children) and sex offenders.   Puberty blockers, however, are known to stunt normal childhood development in children unaffected by precocious puberty.  HHS officials contend that sex reassignment procedures on minors are an unanimously accepted medical practice.  HHS Secretary Becerra testified before Congress that “every major medical association,” “medical journals,” and “scientific and medical evidence” has demonstrated the benefits of transitioning children’s biological sex.  When asked, via a Freedom of Information Act request, for the underlying scientific or medical basis for its position, HHS was only able to produce a two-page brochure that was already publicly available.  In contrast to HHS, a growing body of literature from medical experts and authorities around the world, including those in Europe, caution against performing such procedures on minors.   Courts and government health agencies responsible for determining child welfare have sought to limit child sex reassignment procedures.   Other countries have banned these interventions and surgeries on minors altogether.  An article published in the British Journal of Medicine found “there is great uncertainty about the effects of puberty blockers, cross-sex hormones, and surgeries in young people.”   A court in the United Kingdom noted the obvious about administering puberty blocking chemicals onto children: “[i]t is highly unlikely that a child aged 13 or under would be competent to give consent to the administration of puberty blockers. It is doubtful that a child aged 14 or 15 could understand and weigh the long-term risks and consequences of the administration of puberty blockers.”  In April 2024, the Cass Review , an independent review of gender identity services for children and young people, commissioned by the National Health Service England, found “[w]hile a considerable amount of research has been published in this field, systematic evidence reviews demonstrated the poor quality of the published studies, meaning there is not a reliable evidence base upon which to make clinical decisions, or for children and their families to make informed choices.”   The Cass Review also found that “[t]he rationale for early puberty suppression remains unclear, with weak evidence regarding the impact on gender dysphoria, mental or psychosocial health,” as well as unknown effects on cognitive and psychosexual development.  In August 2024, the American Society of Plastic Surgeons (ASPS) became the first major U.S. medical association to express caution on the use of gender surgery for gender dysphoria in adolescents. In its formal statement, the association stated: “ASPS currently understands that there is considerable uncertainty as to the long-term efficacy for the use of chest and genital surgical interventions for the treatment of adolescents with gender dysphoria, and the existing evidence base is viewed as low quality/low certainty. This patient population requires specific considerations.”   The letter was signed by Committee Chair Cathy McMorris Rodgers (R-WA), Subcommittee on Health Chair Brett Guthrie (R-KY), Subcommittee on Oversight and Investigations Chair Morgan Griffith (R-VA), Rep. Dan Crenshaw (R-TX), Rep. Gus Bilirakis (R-FL), Rep. Buddy Carter (R-GA), Rep. Gary Palmer (R-AL), Rep. Neal Dunn (R-FL), Rep. Randy Weber (R-TX), Rep. Troy Balderson (R-OH), Rep. August Pfluger (R-TX), Rep. Diana Harshbarger (R-TN), and Rep. Kat Cammack (R-FL).  CLICK HERE to read the letter.

Oct 7, 2024
Letter

Chair Rodgers Leads House GOP in Demanding Answers Over FCC Fast-Tracking Democrat Mega-Donor’s Media Takeover Weeks Before Election

Soros-linked fund to acquire more than 200 local radio stations weeks before election Washington, D.C. — House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) led 40 of her Republican colleagues in demanding answers from the Chairwoman of the Federal Communications Commission (FCC) regarding her recent decision to fast-track a media deal allowing the Fund for Policy Reform, a group aligned with Democratic mega-donor George Soros, to buy over 200 radio stations just weeks before the 2024 election. With a party line vote of 3-2, the decision at the Commission level by the Democratic members of the FCC to temporarily waive the required national security review and allow excessive foreign ownership of American radio stations is deeply disturbing. KEY LETTER EXCERPT: “It is highly concerning that the FCC did not follow regular order for a transaction of this magnitude. Licensees and investors need certainty that the FCC will follow its rules and procedures when approving transactions so that the broadcast industry can have the resources it needs to continue serving the public.”  BACKGROUND: Audacy, Inc., a radio broadcasting group, which owns more than 200 radio-station licenses, filed for bankruptcy earlier this year.  Audacy’s filings revealed that a George Soros-backed group known as the Fund for Policy Reform had acquired at least 40 percent of Audacy’s debt.   Audacy estimated that, upon emerging from bankruptcy, 25 percent or more of its stock would be indirectly foreign owned, which triggers FCC review.   This review process requires national security agencies to review the transaction and offer any policy or national security concerns.   On September 30, 2024, the FCC released an Order granting a temporary waiver of this review process, delaying a national security review until after the bankruptcy process is complete and allowing foreign control of a significant number of radio stations across the entire United States, weeks before a national election. CLICK HERE to read Breitbart's exclusive coverage. CLICK HERE to read the full letter.